Alberti KG, Johnston DG, Gill A, et al
The choice depends on priorities: maximum efficacy favors retatrutide, earlier availability and proven safety favors CagriSema
"Since the beginning of social media, I've always wanted people to know that things weren't as fluffy and beautiful as they may seem I knew it would really resonate and make a lot of people feel a lot better about their families, themselves, their own bodies," she said
The CMS BALANCE model offers states a path to expand coverage: states can opt into the model between May 2026 and January 2027, and CMS will negotiate lower drug pricing with manufacturers on behalf of participating states
Our team has found that patients using both report slightly better energy levels during aggressive caloric deficits